Sprint races are a bit like marmite: you either love them or you hate them and they will always divide opinion across the Formula 1 paddock. Max Verstappen has probably been the most vocal as the four ...

EXCLUSIVE: Recently launched Canadian production outfit Sauce Studios is talking to buyers at the TIFF market about new project Josephine The Blanket, which heralds from Dead Man’s Wire writer Austin ...

EU energy chief Dan Jorgensen is confident that a deal to end Russian energy from entering the bloc by 2027 will happen “quite soon”, the Danish Commissioner told reporters, as the bloc faces pressure ...

Aaron T. Ford, an inspector at FBI headquarters, who has a law degree from Rutgers, has been named special agent in charge of the FBI’s Memphis Division. As inspector, he oversaw field office and ...

Local officials were, however, not sure of the height from which the cable car fell. Six persons died after the cable wire of a cargo ropeway snapped at Pavagadh Hill in Gujarat's Panchmahal district ...

Who features for Team Europe at the 2025 Ryder Cup? We look at Luke Donald's confirmed line-up facing Team USA at Bethpage Black this September. The six automatic qualifiers were confirmed after the ...

OAK RIDGE, Tenn.--(BUSINESS WIRE)--Oklo Inc. (NYSE: OKLO) (“Oklo”), an advanced nuclear technology company, today announced plans to design, build, and operate a fuel recycling facility in Tennessee ...

Students at Wichita's Hyde Elementary School wore orange shirts on Tuesday to honor thousands of Indigenous children taken from their parents. A somber day across Kansas as law enforcement and ...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced data from the Phase III HARMONi trial featuring the novel, potential first-in-class ...

JERUSALEM (AP) — Israeli troops and tanks pushed deeper into Gaza City on Wednesday as more people fled the devastated area, and strikes cut off phone and internet services, making it harder for ...

Longer-Term Follow-Up of Western Patients Showed Improving, Favorable Trend in Overall Survival in Global Phase III HARMONi Clinical Trial for Ivonescimab Plus Chemotherapy in 2L+ EGFRm NSCLC With ...